Group assessment
This PHI covers the named group; its members do not have separate PHI ratings.
https://dxm-atlas.org/en/interactions/sertraline-escitalopram-citalopram-fluvoxamine/
CompareKey points for this combination
General concepts in this text
CYP
A family of enzymes involved in chemically transforming drugs.
Metabolism can reduce or increase a substance’s activity.
Sources: CYP
- IUPHAR Pharmacology Education Project: Drug metabolism · Live page accessed 2026-10-12; revision label unavailable
Serotonin
A neurotransmitter: a substance that carries a chemical signal from a nerve cell.
There are different serotonin receptors in the brain and other parts of the body. The response to the signal depends on the receptor and its location.
Sources: Serotonin
- OpenStax: Neural Communication · Introduction to Behavioral Neuroscience, published 2024-11-13
- OpenStax: Neurotransmitters Made from Amino Acids — Serotonin · Introduction to Behavioral Neuroscience, published 2024-11-13
How well is this understood?
Mechanism confidence: high
Confidence in the mechanism: high
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodConfidence in human DXM data: medium
Confidence in direct human evidence involving DXM: medium
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodHow do the substances interact?
How can the effects add up?
ⓘ
SERT
A transporter protein involved in serotonin reuptake.
Inhibiting transport differs from acting on receptors.
Sources: SERT
- IUPHAR Pharmacology Education Project: Receptors · Live page accessed 2026-10-12; revision label unavailable
Serotonin toxicity
A condition caused by excessive serotonin activity in the nervous system.
Also called serotonin syndrome. Features can include tremor and involuntary muscle jerks, raised body temperature, a fast heartbeat, agitation or confusion.
Sources: Serotonin toxicity
- Ables and Nagubilli: Prevention, Diagnosis, and Management of Serotonin Syndrome · American Family Physician 81(9), 1139–1142 (2010)
- Chiew and Isbister: Management of serotonin syndrome (toxicity) · British Journal of Clinical Pharmacology 91(3), 654–661 (2025); first published 26 June 2024; DOI 10.1111/bcp.16152
Sources
- [2] AUVELITY prescribing information · Open publication
- [6] Dextromethorphan, chlorphenamine and serotonin toxicity: case report and systematic literature review · Open publication
- [7] Serotonin syndrome induced by Bromfed DM in a patient on sertraline · Open publication